NASDAQ : CGTX
Cognition Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.6982 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 66.39M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 10.46M | 10.61M | 12.29M | 13.53M | 13.23M | 10.03M |
| Research & Development | 26.14M | 37.19M | 41.68M | 37.20M | 30.32M | 18.57M |
| Operating Expenses | 36.60M | 47.80M | 53.97M | 50.72M | 43.55M | 28.60M |
| Operating Income | -36.60M | -47.80M | -53.97M | -50.72M | -43.55M | -28.60M |
| Interest Expense | -13.00K | -13.00K | -25.00K | -27.00K | -28.00K | -893.00K |
| Currency Exchange Gain (Loss) | -195.00K | |||||
| Other Non Operating Income (Expenses) | 19.84M | 24.32M | 20.21M | 24.96M | 22.18M | 17.33M |
| EBT Excluding Unusual Items | -16.77M | -23.49M | -33.97M | -25.79M | -21.40M | -12.16M |
| Other Unusual Items | 443.00K | |||||
| Pretax Income | -16.77M | -23.49M | -33.97M | -25.79M | -21.40M | -11.72M |
| Net Income | -16.77M | -23.49M | -33.97M | -25.79M | -21.40M | -11.72M |
| Preferred Dividends & Other Adjustments | 4.53M | |||||
| Net Income to Common | -16.77M | -23.49M | -33.97M | -25.79M | -21.40M | -16.25M |
| Shares Outstanding (Basic) | 86.64M | 72.77M | 39.73M | 30.03M | 23.64M | 5.19M |
| Shares Outstanding (Diluted) | 86.64M | 72.77M | 39.73M | 30.03M | 23.64M | 5.19M |
| EPS (Basic) | -0.19 | -0.32 | -0.86 | -0.86 | -0.91 | -3.13 |
| EPS (Diluted) | -0.19 | -0.32 | -0.86 | -0.86 | -0.91 | -3.13 |
| Free Cash Flow | -17.70M | -24.59M | -28.48M | -16.16M | -18.70M | -3.66M |
| Free Cash Flow Per Share | -0.20 | -0.34 | -0.72 | -0.54 | -0.79 | -0.70 |
| EBITDA | -36.55M | -47.76M | -53.86M | -50.63M | -43.47M | -28.50M |
| D&A For EBITDA | 50.00K | 36.00K | 107.00K | 96.00K | 83.00K | 93.00K |
| EBIT | -36.60M | -47.80M | -53.97M | -50.72M | -43.55M | -28.60M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 34.01M | 36.81M | 25.01M | 29.92M | 41.56M | 54.72M |
| Cash & Short-Term Investments | 34.01M | 36.81M | 25.01M | 29.92M | 41.56M | 54.72M |
| Other Receivables | 2.95M | 9.92M | 2.69M | 1.28M | 3.67M | 2.27M |
| Receivables | 2.95M | 9.92M | 2.69M | 1.28M | 3.67M | 2.27M |
| Prepaid Expenses | 586.00K | 1.07M | 1.86M | 3.02M | 2.41M | 2.00M |
| Restricted Cash | 750.00K | 190.00K | ||||
| Total Current Assets | 38.30M | 47.99M | 29.55M | 34.22M | 47.65M | 58.99M |
| Property, Plant & Equipment | 597.00K | 399.00K | 679.00K | 941.00K | 1.05M | 145.00K |
| Other Long-Term Assets | 1.73M | |||||
| Total Assets | 38.90M | 48.39M | 30.23M | 35.16M | 50.42M | 59.14M |
| Accounts Payable | 673.00K | 1.12M | 1.98M | 3.69M | 3.22M | 4.17M |
| Accrued Expenses | 3.83M | 11.99M | 7.62M | 4.05M | 2.09M | 1.75M |
| Short-Term Debt | 78.00K | 307.00K | 279.00K | 544.00K | 634.00K | |
| Current Portion of Leases | 89.00K | 136.00K | 193.00K | 174.00K | 149.00K | |
| Current Unearned Revenue | 777.00K | 367.00K | 1.07M | 1.70M | 1.70M | 753.00K |
| Other Current Liabilities | 1.19M | |||||
| Total Current Liabilities | 5.45M | 13.92M | 11.14M | 10.17M | 7.79M | 7.86M |
| Long-Term Leases | 422.00K | 195.00K | 342.00K | 520.00K | 695.00K | |
| Long-Term Unearned Revenue | 1.69M | |||||
| Total Liabilities | 5.87M | 14.12M | 11.48M | 10.69M | 10.18M | 7.86M |
| Common Stock | 95.00K | 90.00K | 60.00K | 32.00K | 29.00K | 22.00K |
| Additional Paid-In Capital | 240.08M | 232.83M | 193.85M | 165.83M | 155.82M | 145.45M |
| Retained Earnings | -207.15M | -198.65M | -175.16M | -141.19M | -115.40M | -94.00M |
| Comprehensive Income & Other | -195.00K | -199.00K | -198.00K | |||
| Total Common Equity | 33.02M | 34.27M | 18.75M | 24.47M | 40.25M | 51.27M |
| Shareholders' Equity | 33.02M | 34.27M | 18.75M | 24.47M | 40.25M | 51.27M |
| Total Liabilities & Equity | 38.90M | 48.39M | 30.23M | 35.16M | 50.42M | 59.14M |
| Total Debt | 589.00K | 638.00K | 814.00K | 1.24M | 1.48M | |
| Net Cash (Debt) | 33.42M | 36.17M | 24.20M | 28.68M | 40.08M | 54.72M |
| Net Cash Per Share | 0.39 | 0.50 | 0.61 | 0.96 | 1.70 | 10.54 |
| Filing Date Shares Outstanding | 95.09M | 89.35M | 61.97M | 39.00M | 29.26M | 22.58M |
| Total Common Shares Outstanding | 95.06M | 88.90M | 59.85M | 32.17M | 28.99M | 22.23M |
| Working Capital | 32.85M | 34.07M | 18.41M | 24.05M | 39.85M | 51.13M |
| Book Value Per Share | 0.35 | 0.39 | 0.31 | 0.76 | 1.39 | 2.31 |
| Tangible Book Value | 33.02M | 34.27M | 18.75M | 24.47M | 40.25M | 51.27M |
| Tangible Book Value Per Share | 0.35 | 0.39 | 0.31 | 0.76 | 1.39 | 2.31 |
| Machinery | 280.00K | 1.34M | 1.33M | 1.19M | 1.01M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -16.77M | -23.49M | -33.97M | -25.79M | -21.40M | -11.72M |
| Depreciation & Amortization | 245.00K | 228.00K | 266.00K | 252.00K | 235.00K | 93.00K |
| Other Amortization | 383.00K | |||||
| Loss (Gain) From Sale of Assets | 46.00K | 41.00K | ||||
| Stock-Based Compensation | 1.53M | 2.09M | 3.75M | 4.35M | 3.57M | 5.18M |
| Other Operating Activities | -21.00K | 195.00K | 318.00K | -416.00K | ||
| Change in Accounts Receivable | 467.00K | 121.00K | ||||
| Change in Accounts Payable | -5.64M | 3.51M | 1.85M | 2.44M | -749.00K | 2.17M |
| Change in Unearned Revenue | -1.21M | -699.00K | -635.00K | -1.69M | 2.63M | 501.00K |
| Change in Other Net Operating Assets | 4.13M | -6.27M | 69.00K | 4.09M | -3.30M | 55.00K |
| Operating Cash Flow | -17.68M | -24.59M | -28.47M | -16.02M | -18.53M | -3.63M |
| Capital Expenditures | -20.00K | -4.00K | -147.00K | -171.00K | -27.00K | |
| Sale of Property, Plant & Equipment | 9.00K | 9.00K | ||||
| Investing Cash Flow | -11.00K | 9.00K | -4.00K | -147.00K | -171.00K | -27.00K |
| Short-Term Debt Repaid | -353.00K | -739.00K | -811.00K | -1.40M | -268.00K | |
| Total Debt Repaid | -344.00K | -353.00K | -739.00K | -811.00K | -1.40M | -268.00K |
| Net Debt Issued (Repaid) | -344.00K | -353.00K | -739.00K | -811.00K | -1.40M | -268.00K |
| Issuance of Common Stock | 43.78M | 39.33M | 25.76M | 5.33M | 6.94M | 61.25M |
| Repurchase of Common Stock | -288.00K | -164.00K | -128.00K | |||
| Other Financing Activities | -2.25M | -2.25M | -1.33M | -7.78M | ||
| Financing Cash Flow | 40.90M | 36.57M | 23.57M | 4.52M | 5.55M | 53.20M |
| Foreign Exchange Rate Adjustments | 4.00K | -1.00K | -11.00K | |||
| Net Cash Flow | 23.20M | 11.99M | -4.91M | -11.64M | -13.16M | 49.53M |
| Free Cash Flow | -17.70M | -24.59M | -28.48M | -16.16M | -18.70M | -3.66M |
| Free Cash Flow Per Share | -0.20 | -0.34 | -0.72 | -0.54 | -0.79 | -0.70 |
| Levered Free Cash Flow | -23.95M | -31.39M | -28.76M | -23.04M | -26.27M | -10.74M |
| Unlevered Free Cash Flow | -23.94M | -31.38M | -28.75M | -23.02M | -26.25M | -10.56M |
| Change in Working Capital | -2.71M | -3.46M | 1.29M | 4.85M | -943.00K | 2.84M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 67.48M | 119.17M | 29.14M | 59.43M | 60.88M | 139.27M |
| Enterprise Value | 34.06M | 80.22M | 7.71M | 27.19M | 14.98M | 215.72M |
| Last Close Price | 0.70 | 1.35 | 0.70 | 1.85 | 2.10 | 6.32 |
| PB Ratio | 2.01 | 3.48 | 1.55 | 2.43 | 1.51 | 2.72 |
| P/TBV Ratio | 2.02 | 3.48 | 1.55 | 2.43 | 1.51 | 2.72 |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.05 | 0.04 | |
| Net Debt / Equity Ratio | -1.01 | -1.05 | -1.29 | -1.17 | -1.00 | -1.07 |
| Net Debt / EBITDA Ratio | 0.91 | 0.76 | 0.45 | 0.57 | 0.92 | 1.92 |
| Net Debt / FCF Ratio | 1.89 | 1.47 | 0.85 | 1.77 | 2.14 | 14.96 |
| Quick Ratio | 6.78 | 3.36 | 2.49 | 3.07 | 5.80 | 7.25 |
| Current Ratio | 7.03 | 3.45 | 2.65 | 3.37 | 6.11 | 7.50 |
| Return on Equity (ROE) | -83.76% | -88.59% | -157.19% | -79.69% | -46.76% | -60.93% |
| Return on Assets (ROA) | -78.18% | -75.99% | -103.15% | -74.08% | -49.69% | -53.95% |
| Return on Capital Employed (ROCE) | -109.40% | -138.70% | -282.70% | -202.90% | -102.20% | -55.80% |
| Earnings Yield | -27.29% | -19.71% | -116.59% | -43.40% | -35.15% | -8.41% |
| FCF Yield | -26.48% | -20.63% | -97.74% | -27.20% | -30.72% | -2.63% |
| Buyback Yield / Dilution | -65.45% | -83.15% | -32.31% | -27.03% | -355.42% | -921.60% |